Assistant Professor in Geosensing System Engineering at the University of Houston, Texas. His research is funded by NASA, the German Aerospace Center (DLR) and the Italian Space Agency (ASI) and focuses on the synergistic use of remote sensing data exploitation and innovative approaches in Earth and Cryosphere Science and Natural/Anthropogenic Hazard Response.

Board-certified radiation oncologist and pharmaceutical leader with over 14 years of experience in oncology both clinical and in the industry.
In the pharmaceutical industry, he supported drug development, investigator-initiated trials, implementation and execution of medical strategies, and HCPs engagement. Currently, he leads the RMD team, developing Radioligand therapy at Novartis.

Neuroscientist with a Ph.D. focused on brain circuitries underlying memory and learning. With a decade of experience in academia, she researched brain dysfunctions and gut-brain communication in autism spectrum disorder, addiction and other psychiatric conditions. She now works at AbbVie, supporting psychiatric drug development, bridging industry-clinician communication, providing medical education, and identifying clinical needs.

Assistant Professor in the GU Medical Oncology Department, UT MD Anderson Cancer Center. She uses tissue engineering, intravital multiphoton microscopy, and computational oncology to understand the mechanisms that support the progression of bone metastases and their response to therapy. Holds a PhD in Cell and Molecular Biology from the Università Vita-Salute San Raffaele, Milano.

Assistant Research Professor with the Center for Computational Surgery at Houston Methodist Research Institute, Houston, Texas. He works on developing computational models to advance the knowledge of complex physiological systems and test therapies and treatments digitally. He holds a Ph.D. in applied math from the University of La Rochelle, France.